EX-99.2 3 d308499dex992.htm EX-99.2 EX-99.2

Exhibit 99.2

Appendix 3Y

Change of Director’s Interest Notice

 

 

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

 

Name of Entity:

  PRIMA BIOMED LIMITED (ASX:PRR)

ACN:

  90 009 237 889

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

 

Name of Director:

  

Mr Pete Meyers

 

Date of Last Notice:

  

4 October 2016

 

Part 1 – Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Direct or indirect interest

 

  

Direct

 

Nature of indirect interest

(including registered holder)

Note: Provide details of the circumstances giving rise to the relevant interest.

 

   N/A

Date of change

  

6 December 2016

 

No. of securities held prior to change

 

1)     Ordinary Fully Paid Shares

 

           Shares   Options    
           
       Direct   6,862,744      
           
       Indirect                
           
       Total   6,862,744      
              
   

857,844 Performance Rights

 

Class

 

Performance Rights 

 

 

+ See chapter 19 for defined terms.

    

11/3/2002

   Appendix 3Y Page 1


Appendix 3Y

Change of Director’s Interest Notice

 

 

 

Number acquired                                                   

10,023,350

 

Number disposed

 

Nil

 

Value/Consideration

Note: If consideration is non-cash, provide details and estimated valuation

 

Calculated based on 3.67 years directors’ fees of $105,000 per annum divided by $0.0384 (being the 5 day VWAP up to and including 9 September 2016).

 

No. of securities held after change

 

2)     Ordinary Fully Paid Shares

 

                   Shares                   Options            
           
       Direct   6,862,744      
           
       Indirect                
           
       Total   6,862,744      
              
   

3)     10,881,194 Performance Rights

 

Nature of change

Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

 

Issued to Pete Meyers in lieu of cash for his services as a non-executive director, in accordance with sjareholder approval at the AGM held on 25 November 2016.

 

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

 

Detail of contract     
      
Nature of interest     
      

Name of registered holder

(if issued securities)

    
      
Date of change     
      

 

 

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

   11/3/2002


Appendix 3Y

Change of Director’s Interest Notice

 

 

 

No. and class of securities to which interest related prior to change

Note: Details are only required for a contract in relation to which the interest has changed

    
      
Interest acquired     
      
Interest disposed     
      

Value/Consideration

Note: If consideration is non-cash, provide details and an estimated valuation

    
      
Interest after change     
      

Part 3 – +Closed Period

 

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?    No
      
If so, was prior written clearance provided to allow the trade to proceed during this period?     
      
If prior written clearance was provided on what date was this provided?     
      

 

 

+ See chapter 19 for defined terms.

11/3/2002

   Appendix 3Y Page 3